Taking care of patients and their communities is at the heart of what hospitals do, and that wouldn’t be possible without the clinical services that hospitals provide. These services touch all aspects of a hospital’s operations, ranging from the emergency department to behavioral health. Through its numerous area-specific groups, CHA provides advocacy and representation on all aspects of operations — guiding hospitals in meeting regulatory, legal, and licensing requirements.
About Clinical Care
CHA has submitted comments to the Food and Drug Administration (FDA) on its revised draft guidance on hospital and health system compounding under Section 503A of the Federal Food, Drug, and Cosmetic Act. In the letter, CHA applauds the agency for revising its earlier 2016 draft guidance to eliminate the previously proposed policy that would have established a one-mile radius requirement as criteria for medication distribution by a hospital or health […]
On Nov. 30, a federal district court in Louisiana issued a preliminary injunction temporarily blocking enforcement of the Centers for Medicare & Medicaid Services (CMS) interim final rule requiring COVID-19 vaccinations for workers in most health care settings that receive Medicare or Medicaid reimbursement.
As hospital staff report an increase in the frequency of violent acts in the emergency department, inpatient, and outpatient settings, CHA will host a members-only webinar on Dec. 15 from 9 to 10:15 a.m. (PT) that will review Cal/OSHA workplace violence mitigation plan requirements. The webinar will also discuss the American Hospital Association Hospitals Against Violence Initiative, featuring the Creating Safer Workplaces guide. […]
CHA is hosting a members-only webinar on December 15 that will review Cal/OSHA Workplace Violence Mitigation plan requirements. They will also discuss the American Hospital Association Hospitals Against Violence Initiative, featuring the Creating Safer Workplaces guide.
The Food & Drug Administration (FDA) has reversed the prior administration’s policy on pre-market review exception for COVID-19 laboratory-developed tests that allowed the tests to be offered prior to or without FDA authorization.
The Centers for Medicare & Medicaid Services will host a webinar on Nov. 10 at 12:30 p.m. (PT) to provide updates and key information on the Medicare clinical laboratory fee schedule (CLFS) private payer data collection and reporting policies. Registration is required. The next CLFS data reporting period for clinical diagnostic laboratory tests is Jan. 1 through March 31, 2022, and is based on the original data collection period of Jan. 1 through June 30, 2019.
The Centers for Medicare & Medicaid Services (CMS) has issued an interim final rule with comment period, requiring COVID-19 vaccinations for workers in most health care settings that receive Medicare or Medicaid reimbursement, including but not limited to hospitals, dialysis facilities, ambulatory surgical settings, home health agencies, and long-term care facilities.
The Centers for Medicare & Medicaid Services (CMS) implemented in 2009 the Electronic Prescribing (eRx) Incentive Program, which uses incentive payments and payment adjustments to encourage the use of qualified electronic prescribing systems. For questions regarding the eRx Incentive Program or eRx payment adjustments, or for assistance submitting a hardship exemption request, contact the QualityNet Help Desk at (866) 288-8912 (TTY 1-877-715-6222) or via [email protected] For additional information and resources, visit www.CMS.gov/ERxIncentive
On Oct. 20, the Food and Drug Administration amended the emergency use authorization for COVID-19 vaccines to allow booster doses for the Moderna and Johnson & Johnson vaccines. The Centers for Medicare & Medicaid Services has released new billing coding for the Johnson & Johnson and Moderna COVID-19 vaccine booster shots. Current billing codes, payment allowances, and effective dates are available online.
The Centers for Disease Control and Prevention (CDC) has issued operational planning information to prepare jurisdictions for the eventual distribution and administration of COVID-19 vaccines to the pediatric population.